New capabilities make relevant information easier to find, bring key priorities into focus, and strengthen governance across the architecture landscape.

DUBLIN, Aug. 3, 2026 /PRNewswire/ — BOC Group today announced the release of ADOIT 20.0, the latest version of their EA suite. The release helps organizations cut through architecture complexity, bring priorities into focus, and act on information they can trust.

As Enterprise Architecture supports more teams and transformation initiatives, maintaining a complete repository is no longer enough. Organizations need accessible information, clear priorities, and reliable data. ADOIT 20.0 responds with connected capabilities for discovery, visibility, governance, and application assessment.

An enhanced search experience helps users find relevant information faster with less query maintenance. Dynamic filters adapt to the current user or date, keeping recurring searches useful as responsibilities and timeframes change.

New Configurable Dashboards bring the architecture data that matters to each user into one personalized view. Flexible widgets provide control over what to display, how to visualize it, and how to arrange the dashboard, which can then be saved and shared.

The new Application Compliance Assessment workspace helps organizations evaluate applications against defined principles, constraints, and requirements. Summary views and heatmaps reveal gaps, compare results, and focus improvement where it is needed most.

Forms Approvals strengthen governance by ensuring proposed repository changes are reviewed before implementation. This helps maintain accurate, consistent architecture data, clarify responsibilities, and build trust in the information teams rely on.

“ADOIT 20.0 helps teams reach the information that matters, shape it around their needs, and rely on it with confidence,” said Christoph Moser, ADOIT Product Manager. “Together, these capabilities make Enterprise Architecture more accessible, focused, and actionable.”

Beyond the user-facing capabilities, ADOIT 20.0 builds on a modern, fully containerized Linux-based foundation – enabling faster innovation while preserving deployment flexibility, an open data model, and enterprise-grade security.

The new release is available immediately to SaaS customers on the BOC AWS Cloud. More information is available on the BOC Group website.

About the BOC Group

BOC Group crafts and markets Enterprise Modelling Software for BPM, EA, and GRC, helping organizations manage complexity and transformation in the digital era. Its interconnected and adaptable tools integrate with a wide range of ecosystem applications.

ADOIT customers include Allianz, Dentsu Aegis, iHeartMedia, PostFinance, Vienna International Airport, and many others.

Press Contact:
BOC Information Technologies Consulting GmbH
Michael Kamberov
Global Market Development Manager
+43-1-905 10 71-0
michael.kamberov@boc-group.com 

Logo – https://mma.prnewswire.com/media/3008272/BOC_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/adoit-20-0-introduces-dynamic-search-configurable-dashboards-and-application-compliance-assessment-302841041.html

Combining HUMAIN’s full AI stack with MOZN’s deep AI product expertise and forward-deployed engineering to deliver secure, enterprise-grade AI solutions for financial institutions and public sector organizations.

HUMAIN has made a strategic investment in Saudi AI company MOZN, combining HUMAIN’s full AI stack with MOZN’s enterprise AI products and Forward Deployed Engineering expertise to accelerate secure, production-scale AI deployments for financial institutions as well as public sector organizations.This investment marks one of the first made through HUMAIN Ventures and represents HUMAIN’s first investment in a Saudi company. The partnership also represents one of the first strategic engagements under HUMAIN’s newly launched Banking, Financial Services and Insurance (BFSI) sector, establishing a flagship collaboration to accelerate sovereign AI adoption across financial institutions. Co-developed enterprise AI solutions will be made available through the HUMAIN ONE AI Agent Marketplace, enabling organizations to securely deploy and scale trusted AI applications. The first jointly developed solutions and customer deployments will be unveiled at LEAP Riyadh, with broader commercial availability planned for H2 2026. 

RIYADH, Saudi Arabia, Aug. 3, 2026 /PRNewswire/ — HUMAIN, a PIF company delivering full-stack artificial intelligence capabilities globally, today announced a strategic investment in and partnership with MOZN a global leader in enterprise AI for high-assurance domains, based in Saudi Arabia. 

The investment builds on MOZN’s strong momentum as a regional leader in enterprise AI, serving more than 150 customers across the financial services and public sector. The funding will support MOZN’s international expansion and accelerate the global scale-up of its AI Platform. 

The collaboration comes as financial services enters a new phase of AI adoption. According to the Cambridge Centre for Alternative Finance, 81% of financial services firms are adopting AI in at least one business function. Further, generative AI is projected to unlock between US$200 billion and US$340 billion in annual value across the banking sector as reported by McKinsey. At the same time, digital payments continue to grow at approximately 15% annually (McKinsey), reinforcing the need for trusted, secure AI infrastructure and intelligent automation. 

The partnership will accelerate the adoption of sovereign AI across financial institutions and the public sector, enabling organizations to move from pilots to secure, production-scale deployments. 

At the core of the partnership is a shared ambition to set a new benchmark for enterprise AI in high-assurance environments. By combining HUMAIN’s locally operated full AI stack, including products such as HUMAIN Fabric and HUMAIN ONE, alongside its next-generation data centers, and advanced models, with MOZN’s AI products, deep regulatory expertise and Forward Deployed Engineering (FDE) model, the two organizations will deliver scalable, compliant, and production-grade AI systems. 

Driving Production-Scale AI for High-Assurance Domains 

Central to the partnership, both companies will co-develop solutions with early clients through a shared product roadmap and coordinated go-to-market approach. Initial priority use cases will focus on financial crime prevention, knowledge intelligence, and Governance, Risk & Compliance (GRC). 

MOZN’s Forward Deployed Engineering model will play a central role, embedding engineers directly within client environments to co-design, deploy, and scale real-world AI applications. This approach ensures that AI initiatives translate into measurable business outcomes. 

Co-developed solutions will also be made available through the HUMAIN ONE AI Agent Marketplace, providing organizations with a trusted, sovereign channel to discover, deploy, and scale enterprise-grade AI agents. 

Tareq Amin, CEO HUMAIN, said: 

“Enterprise AI only delivers value when organizations can deploy it securely, reliably, and at production scale. This partnership reflects the momentum of HUMAIN’s recently launched Banking, Financial Services and Insurance (BFSI) sector, and represents one of our first strategic engagements for the sector as we build an ecosystem of partners to transform financial services and the public sector through AI. Our first investment in a Saudi company with MOZN strengthens our ability to deliver production-grade AI solutions for highly regulated environments, enabling measurable operational impact while expanding access to these capabilities across regional and global markets.” 

Dr Mohammed AlHussein, Founder & Chief Executive Officer, MOZN, added: 

“This investment from HUMAIN is a strong endorsement of MOZN’s mission to empower enterprises with intelligence that matters. As complexity, scale, and regulatory expectations accelerate across industries, institutions need AI that is sovereign, trusted, and built for high-assurance domains. Together with HUMAIN, we are combining world-class infrastructure with deep domain expertise to co-create category-defining solutions built for financial institutions and public sector organizations.” 

From Pilots to Production 

The first co-developed solutions and live client deployments will be unveiled at LEAP Riyadh,. Broad availability across financial services and the public sector is planned for H2 2026. 

About HUMAIN:  

HUMAIN, a PIF company, is a global artificial intelligence company delivering full-stack AI capabilities across four core areas: next-generation data centers; hyper-performance infrastructure and cloud platforms; advanced AI models, including some of the world’s most advanced Arabic large language models developed in the Arab world; and transformative AI solutions that combine deep sector insight with real-world execution. 

HUMAIN’s end-to-end model serves both public and private sector organizations, unlocking value across industries, driving digital transformation, and strengthening capabilities through human–AI collaboration. With a growing portfolio of sector-specific AI products and a core mission focused on intellectual property development and global talent leadership, HUMAIN is engineered for international competitiveness and technological excellence. 

Forward-Looking Statement: 

This press release may contain forward-looking statements based on current expectations and assumptions. Actual results may differ materially due to various risks and uncertainties. HUMAIN undertakes no obligation to update these statements. 

Media Inquiries: 

For further details about HUMAIN, please visit humain.com. 

For media inquiries, please contact: 
Hana Nemec
Head of Communications & PR
pr@humain.com
Follow HUMAIN on: X | LinkedIn

About MOZN:

MOZN is an enterprise AI company empowering financial institutions and public sector organizations with intelligence that matters.

Purpose-built for high-assurance domains, MOZN delivers solutions for financial crime prevention, knowledge and decision intelligence. Through its AI platform, MOZN combines sovereign AI capabilities, advanced AI products, and forward-deployed engineering expertise to connect data, generate intelligence, and drive measurable outcomes.

MOZN has created strong momentum as a regional leader in enterprise AI, serving more than 150 customers across the financial services and public sector across the region and beyond, and earning recognition from leading industry analysts, including Forrester, Gartner, and IDC.

Headquartered in Riyadh, MOZN serves customers across the region and beyond, helping organizations solve complex challenges where trust, compliance, and security are non-negotiable.

Media Inquiries:

For more information about MOZN, please visit mozn.ai. 

For media inquiries, please contact:
Mohammed Alenazi,
Head of Communications & PR:
media@mozn.ai
Follow MOZN on: X | LinkedIn

View original content to download multimedia:https://www.prnewswire.com/news-releases/humain-makes-investment-in-mozn-and-partners-to-co-build-enterprise-ai-solutions-locally-and-globally-302841043.html

SOURCE MOZN

SAN JOSE, Calif., Aug. 3, 2026 /PRNewswire/ — Invenio Imaging, a leader in fresh tissue imaging and artificial intelligence, announced today the completion of patient enrollment in the ON-SITE study, its U.S. pivotal study evaluating NIO® Lung Cancer Reveal, an AI-based image analysis module for the rapid assessment of bronchoscopic lung biopsy specimens imaged with the NIO® Imaging System.

With 1,006 patients enrolled, ON-SITE is one of the largest prospective, multicenter studies conducted in interventional pulmonology. The study collected more than 3,250 fresh biopsy specimens across seven medical centers, with participation from 32 physicians. Specimens were obtained using transbronchial forceps biopsy, cryobiopsy, transbronchial needle aspiration, and endobronchial ultrasound-guided transbronchial needle aspiration.

“Completing enrollment in ON-SITE is a major milestone for Invenio and for our Lung Cancer Reveal program,” said Jay Trautman, PhD, co-founder and CEO of Invenio Imaging. “We are incredibly grateful to the patients, investigators, clinical research teams, participating institutions, and Invenio colleagues who supported this study. Their dedication and collaboration made a clinical effort of this scale possible and have brought us an important step closer to providing rapid, AI-enabled tissue assessment in the bronchoscopy room.”

Despite major advances in bronchoscopy, determining whether a biopsy contains the tissue needed for diagnosis during a procedure remains a significant challenge. Rapid on-site evaluation (ROSE) can provide immediate feedback but requires specialized pathology personnel and is not consistently available.

“As bronchoscopic procedures become more advanced, our ability to assess the tissue collected during the procedure has not generally kept pace,” said Dr. Gustavo Cumbo-Nacheli, interventional pulmonologist in Grand Rapids and a principal investigator for the ON-SITE study. “There is an urgent clinical need for rapid feedback that can help physicians evaluate tissue in the procedure suite. A practical, in-room approach to tissue assessment could have a meaningful impact on bronchoscopy workflows.”

The NIO® Imaging System rapidly images fresh, unprocessed biopsy tissue without traditional freezing, sectioning, or staining, while preserving the specimen for downstream pathology and molecular analysis. NIO® Lung Cancer Reveal applies artificial intelligence to these images to assist physicians in the evaluation of bronchoscopic lung biopsy specimens.

“The scale of ON-SITE is remarkable and reflects an extraordinary collaborative effort across the participating centers,” said Dr. George Cheng, interventional pulmonologist in San Diego and a principal investigator for the ON-SITE study. “Investigators and research teams worked together to enroll patients and collect thousands of specimens across multiple bronchoscopic biopsy techniques. We are proud to have contributed to a prospective study of this scope and importance.”

NIO® Lung Cancer Reveal received FDA Breakthrough Device Designation for its intended use to assist physicians in the evaluation of bronchoscopic lung forceps biopsies. The NIO® Lung Cancer Reveal detects cell/tissue morphology suspicious for cancer in images acquired with the NIO® Imaging System from fresh/unprocessed biopsy specimens. Its output should not be used as the primary diagnosis and physicians should consider all other clinical factors when making a clinical decision. Invenio will analyze the ON-SITE pivotal validation data in support of its regulatory submission. NIO® Lung Cancer Reveal remains investigational in the United States and has not been cleared or approved for clinical use.

About Invenio Imaging Inc.

Invenio Imaging is an emerging, privately held medical device company based in San Jose, California, dedicated to advancing the care of cancer patients by combining fresh tissue imaging and artificial intelligence. The NIO® Imaging System enables rapid imaging of fresh, unprocessed tissue and has been used across a range of surgical and interventional applications.

Invenio Imaging’s first AI product, NIO® Glioma Reveal, is CE-marked and available for clinical use in Europe. NIO® Lung Cancer Reveal, the AI product evaluated in the ON-SITE study, has not been cleared or approved for clinical use in the United States.

Research reported in this press release is supported by the National Cancer Institute of the National Institutes of Health under Award Number 1R44CA281581-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

CONTACT: contact@invenio-imaging.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/invenio-imaging-announces-completion-of-enrollment-in-landmark-study-of-ai-based-image-analysis-for-lung-cancer-302840042.html

SOURCE Invenio Imaging